Hormonal Therapy for Prevention of Respiratory Distress Syndrome

Fetal and Neonatal Physiology: Third Edition

Volumn 2-2, Issue , 2003, Pages 1069-1074

  Gross, Ian ^a,b   Ballard, Philip L ^c,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84911118491     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9654-6.50108-9     Document Type: Chapter

References (47)

1. Kresch MJ, Gross I The biochemistry of fetal lung surfactant. Clin Perinatol 1987, 14:481.
2. Ballard PL Hormonal regulation of pulmonary surfactant. Endocr Rev 1989, 10:165.
3. Ballard PL, Ballard RA Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 1995, 173:254.
4. Muglia L, et al. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 1995, 373:427.
5. Cole TJ, et al. GRKO mice express an aberrant dexamethasone-binding glucocorticoid receptor, but are profoundly glucocorticoid resistant. Mol Cell Endocrinol 2001, 173:193.
6. Venkatesh VC, Ballard PL Glucocorticoids and gene expression. Am J Respir Cell Mol Biol 1991, 4:301.
7. Odom MW, et al. Hormonally regulated proteins in cultured human fetal lung: analysis by two-dimensional polyacrylamide gel electrophoresis. Am J Physiol 1990, 259:L283.
8. Ballard PL The glucocorticoid domain in the lung and mechanisms of action. Endocrinology of the Lung: Development and Surfactant Synthesis 2000, 1. Humana Press, Totowa NJ. C.R. Mendelson (Ed.).
9. Ikegami M Minimum interval from fetal betamethasone treatment to postnatal lung responses in preterm lambs. Am J Obstet Gynecol 1996, 174:1408.
10. Effects of antenatal dexamethasone administration on the prevention of respiratory distress syndrome. Am J Obstet Gynecol 1981, 141:276. Collaborative Group on Antenatal Steroid Therapy, .
11. Liggins GC The prevention of RDS by maternal betamethasone administration. 70th Ross Conference Report. Lung Maturation and the Prevention of Hyaline Membrane Disease 1976, 1989. Ross Laboratories, Columbus, OH.
12. Liley HG, et al. Regulation of messenger RNAs for the hydrophobic surfactant proteins in human lung. J Clin Invest 1989, 83:1191.
13. Tan RC, et al. Developmental and glucocorticoid regulation of surfactant protein mRNAs in preterm lambs. Am J Physiol 1999, 277:L1142.
14. Guinn DA, et al. Single vs. weekly courses of antenatal corticosteroids for women at risk of preterm delivery: a randomized controlled trial. JAMA 2001, 286:1581.
15. Adcock IM, Caramori G Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol Cell Biol 2001, 79:376.
16. Gross I, et al. Glucocorticoid-thyroid hormone interactions in fetal rat lung. Pediatr Res 1984, 18:191.
17. Gonzales LW, et al. Glucocorticoids and thyroid hormones stimulate biochemical and morphological differentiation of human fetal lung in organ culture. J Clin Endocrinol Metab 1986, 62:678.
18. Liggins GC, et al. Synergism of cortisol and thyrotropin-releasing hormone in lung maturation in fetal sheep. J Appl Physiol 1988, 65:1880.
19. Gonzales LK, Ballard PL Identification and characterization of nuclear T3-binding sites in fetal human lung. J Clin Endocrinol Metab 1981, 53:21.
20. Romaguera J, et al. Responsiveness of L-S ratio of the amniotic fluid to intra-amniotic administration of thyroxine. Am Obstet Gynecol Scand 1990, 69:119.
21. Liggins GC, Howie RN A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome. Pediatrics 1972, 50:515.
22. Consensus Development Conference on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes National Institutes of Health. JAMA 1995, 273:413.
23. Crowley P Promoting pulmonary maturity. Effective Care in Pregnancy 1989, Vol 1:746. Oxford University Press, Oxford, UK. I.M. Chalmers, M.J.N.C. Keirse (Eds.).
24. Crowley P Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol 1995, 173:322.
25. Garite TJ, et al. A randomized, placebo controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 weeks' gestation. Am J Obstet Gynecol 1992, 166:646.
26. Smolders-de Haas H, et al. Physical development and medical history of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome: a 10 to 12 year follow-up. Pediatrics 1990, 86:65.
27. Schmand B, et al. Psychological development of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome. Pediatrics 1990, 86:58.
28. Gamsu HR, et al. Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants: report of a UK multicentre trial. Br J Obstet Gynaecol 1989, 96:401.
29. Ikegami M, et al. Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. Am J Respir Crit Care Med 1997, 156:178.
30. Banks BA, Cnaan A, Morgan M, et al. Multiple courses of antenatal corticoids and outcome of premature neonates. Am J Ob Gynecol 1999, 181:709.
31. Banks BA, et al. Multiple courses of antenatal corticosteroids are associated with early severe lung disease in preterm neonates. J Perinatol 2002, 22:101.
32. Antenatal Corticosteroids revisited Repeat courses. NIH Consensus Statement Online 2000, 17:2. Accessed August 17-18, 2000.
33. Baud O, et al. Antenatal glucocorticoid treatment and cystic periventricular leucomalacia in very premature infants. N Engl J Med 1999, 341:1190.
34. Baud O, et al. Neurotoxic effects of fluorinated glucocorticoid preparations on the developing mouse brain: role of preservatives. Pediatr Res 2001, 50:706.
35. Thebaud B, et al. Postnatal glucocorticoids in very preterm infants: "The good, the bad and the ugly"?. Pediatrics 2001, 107:413.
36. Fiascone JM, et al. Betamethasone increases pulmonary compliance in part by surfactant independent mechanisms in preterm rabbits. Pediatr Res 1987, 22:730.
37. Ikegami M, et al. Corticosteroids and surfactant change lung function and protein leaks in the lungs of ventilated premature rabbits. J Clin Invest 1987, 79:1371.
38. Schellenberg JC, Liggins GC Growth, elastin concentration and collagen concentration of perinatal rat lung: effects of dexamethasone. Pediatr Res 1987, 21:603.
39. Kari MA, et al. Prenatal dexamethasone treatment in conjunction with human surfactant therapy-a randomized placebo-controlled multicenter study. Pediatrics 1994, 93:730.
40. Roti E, et al. Human cord blood concentrations of thyrotropin, thyroglobulin, and iodothyronines after maternal administration of thyrotropin-releasing hormone. J Clin Endocrinol Metab 1981, 53:813.
41. Moya F, et al. Effect of maternal administration of thyrotropin releasing hormone on the preterm fetal pituitary-thyroid axis. J Pediatr 1991, 119:966.
42. Ballard PL, Ballard RA, Creasy RK, et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after prenatal treatment with thyrotropin-releasing hormone. Pediatr Res 1992, 32:673.
43. Moya FR, Gross I Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences. Sem Perinatol 1993, 17:267.
44. Ballard RA, et al. Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants. N Engl J Med 1998, 338:493.
45. Collaborative trial of prenatal thyrotropin-releasing hormone and corticosteroids for prevention of respiratory distress syndrome. Am J Obstet Gynecol 1998, 178:33. Collaborative Santiago Surfactant Group.
46. Alfirevic Z, et al. Two concurrent randomised trials of antenatal thyrotropin-releasing hormone for fetal maturation: stopping before the due date. Br J Obstet Gynecol 1999, 106:898.
47. Gross I, Moya FR Is there a role for antenatal TRH in the prevention of neonatal respiratory disorders. Semin Perinatol 2001, 25:406.